These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1714733)

  • 21. Mass fragmentographic analysis of monoamine metabolites in the spinal cord of rat after the administration of morphine.
    Commissiong JW
    J Neurochem; 1983 Nov; 41(5):1313-8. PubMed ID: 6194263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of acute doses of buprenorphine on concentrations of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) in the rat forebrain [proceedings].
    Cowan A; Dettmar PW; Walter DS
    Br J Pharmacol; 1976 Oct; 58(2):275P. PubMed ID: 974396
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nimodipine on biogenic amines in discrete brain areas.
    Gaggi R; Gianni AM; Chirivi L; Roncada P
    Pharmacology; 1992; 44(5):237-44. PubMed ID: 1377827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
    Thiblin I; Finn A; Ross SB; Stenfors C
    Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine.
    Peinado J; Hameg A; Garay RP; Bayle F; Nuss P; Dib M
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):134-9. PubMed ID: 12595954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal stress alters monoamine metabolites in fetal and neonatal rat brain.
    Herrenkohl LR; Ribary U; Schlumpf M; Lichtensteiger W
    Experientia; 1988 May; 44(5):457-9. PubMed ID: 3371452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat.
    Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Mura MA; De Natale G; Miele E; Miele M
    Brain Res; 1996 Jun; 723(1-2):154-61. PubMed ID: 8813393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous determination of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid in brain tissue, using a double-column procedure.
    Moroji T; Hagino K; Yamaguchi K
    Arzneimittelforschung; 1985; 35(2):478-80. PubMed ID: 2581588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis by HPLC-EC of metabolites of monoamines in fetal and postnatal rat brain.
    Ribary U; Schlumpf M; Lichtensteiger W
    Neuropharmacology; 1986 Sep; 25(9):981-6. PubMed ID: 2430230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immediate and "day-after" effects of morphine on dopamine and serotonin metabolism in various structures of the rat brain.
    Antkiewicz-Michaluk L; Romańska I; Vetulani J
    Pol J Pharmacol; 1995; 47(4):355-8. PubMed ID: 8616517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of N-ethyl,N-nitrosourea on monoamine concentrations and metabolizing enzymes in mouse brain regions.
    Jayasekara S; Sharma RP; Drown DB
    Eur J Pharmacol; 1992 May; 228(1):37-44. PubMed ID: 1383012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional effects of ceruletide, a cholecystokinin-8 analog, on the striatal monoaminergic systems in food-deprived mice.
    Yamada T; Kimura H
    Brain Res; 1991 Feb; 540(1-2):25-30. PubMed ID: 1711395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidity.
    Wiesel FA; Fyrö B; Nybäck H; Sedvall G; Wode-Helgodt B
    Biol Psychiatry; 1982 Dec; 17(12):1403-13. PubMed ID: 6186299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
    Kaakkola S; Wurtman RJ
    Brain Res; 1992 Aug; 587(2):241-9. PubMed ID: 1381981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.
    Mendelsohn FA; Jenkins TA; Berkovic SF
    Brain Res; 1993 Jun; 613(2):221-9. PubMed ID: 7514480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone and lithium interaction on the levels of homovanillic acid in the rat brain.
    Genç E; Hizal A; Eroğlu L
    Pol J Pharmacol Pharm; 1987; 39(1):41-5. PubMed ID: 3671187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptics increase striatal catecholamine metabolites but not ascorbic acid in dialyzed perfusate.
    Blakely RD; Wages SA; Justice JB; Herndon JG; Neill DB
    Brain Res; 1984 Aug; 308(1):1-8. PubMed ID: 6206916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Caliguri EJ; Johannessen JN
    Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of psychoactive drugs to rat brain amine receptors, measured ex vivo, and their effects on the metabolism of biogenic amines.
    Burki HR
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):258-66. PubMed ID: 2423886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.